Stivarga (regorafenib) — Medica
Uterine sarcoma
Initial criteria
- age ≥ 18 years
- recurrent, advanced, inoperable, or metastatic disease
- tried at least one systemic regimen (examples: doxorubicin, docetaxel, gemcitabine, ifosfamide, dacarbazine, epirubicin, vinorelbine)
Approval duration
1 year